Company Auspex Pharmaceuticals Inc
Equities
US05211J1025
Biotechnology & Medical Research
End-of-day quote
Other stock markets
|
||
- USD | - |
2015 | Auspex Pharmaceuticals : Teva Pharmaceutical's history of key acquisitions | RE |
2015 | Auspex Pharmaceuticals : Teva's turnaround CEO sets sights on $40 billion mega-deal | RE |
Managers
Managers | Title | Age | Since |
---|---|---|---|
Brendan O'Grady
CEO | Chief Executive Officer | 57 | - |
Members of the board
Members of the board | Title | Age | Since |
---|---|---|---|
Rod A. Ferguson
BRD | Director/Board Member | 67 | 01/13/01 |
Alex Zisson
BRD | Director/Board Member | 54 | 17/13/17 |
Sep Sarshar
FOU | Founder | 57 | 28/01/28 |
Share class
Vote | Quantity | Free-Float | Company-owned shares | Total Float | |
---|---|---|---|---|---|
Stock A | 1 | 32,439,897 | 25,606,628 ( 78.94 %) | 624,710 ( 1.926 %) | 78.94 % |
Company contact information
Auspex Pharmaceuticals, Inc.
3366 North Torrey Pines Court Suite 400
92037, San Diego
+858 558 2400
http://www.auspexpharma.comSector
1st Jan change | Capi. | |
---|---|---|
+8.96% | 105B | |
-1.43% | 104B | |
+4.40% | 22.94B | |
-12.15% | 22.34B | |
-4.36% | 19.25B | |
-39.98% | 17.08B | |
-10.04% | 16.96B | |
+38.61% | 12.63B | |
+313.59% | 8.49B |
- Stock Market
- Equities
- Stock
- Company Auspex Pharmaceuticals Inc